Mark John Austin
CIK 1713059 · VP Finance/Prin Fin&Acct Offic · last filed 2024-07-19
Mark John Austin is a VP Finance/Prin Fin&Acct Offic who has filed 13 SEC Form 4 insider transactions across 2 companies since 2017. The most recent filing, for CATX, was dated Jul 19, 2024. Across all open-market trades the lifetime net is +$22.6K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $247.9K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$247.9K
2
13
$22.6K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CATX | VP Finance/Prin Fin&Acct Offic | 84,030 | $2.95 | $247.9K | $0 | 3 | 2024-07-19 |
| Perspective Therapeutics, Inc. (ISR) Delisted | VP Finance/Prin Fin&Acct Offic | 40,230 | $0.38 | $15.4K | $22.6K | 10 | 2022-08-11 |
Recent Filings
13 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-07-19 | CATX | Grant (A) | — | $0 | EDGAR |
| 2024-04-24 | CATX | Exer (M) | +30,000 | $10.8K | EDGAR |
| 2023-06-14 | CATX | Grant (A) | — | $0 | EDGAR |
| 2022-08-11 | Perspective Therapeutics, Inc. (ISR) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-06-09 | Perspective Therapeutics, Inc. (ISR) Delisted | Buy (P) | +18,800 | $5.4K | EDGAR |
| 2021-07-06 | Perspective Therapeutics, Inc. (ISR) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-10-28 | Perspective Therapeutics, Inc. (ISR) Delisted | Buy (P) | +19,230 | $10.0K | EDGAR |
| 2020-06-25 | Perspective Therapeutics, Inc. (ISR) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-06-24 | Perspective Therapeutics, Inc. (ISR) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-11-20 | Perspective Therapeutics, Inc. (ISR) Delisted | Buy (P) | +4,283 | $1.7K | EDGAR |